Hampton Malcolm Garret
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Hampton Malcolm Garret. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| QTRX | Award / Grant | 46,727 | — | — | Nov 20, 2025 | |
| ILMN | SVP Clinical Genomics Group | Tax Withholding | 326 | $334.60 | $109,080 | Jan 9, 2020 |
| ILMN | SVP Clinical Genomics Group | Tax Withholding | 492 | $300.87 | $148,028 | Nov 5, 2019 |
| ILMN | SVP Clinical Genomics Group | Tax Withholding | 327 | $305.24 | $99,813 | Jan 9, 2019 |
| ILMN | EVP Clinical Genomics Group | Award / Grant | 1,901 | — | — | Dec 11, 2018 |
| ILMN | EVP Clinical Genomics Group | Tax Withholding | 253 | $324.14 | $82,007 | Nov 5, 2018 |
| ILMN | SVP Clinical Genomics Group | Tax Withholding | 358 | $242.80 | $86,922 | Jan 9, 2018 |
| ILMN | EVP Clinical Genomics Group | Award / Grant | 2,920 | — | — | Dec 11, 2017 |